Nothing Special   »   [go: up one dir, main page]

ATE231017T1 - Testsatz und verfahren zur qualitätsprüfung von einem iontophoretischen probenahmesystem - Google Patents

Testsatz und verfahren zur qualitätsprüfung von einem iontophoretischen probenahmesystem

Info

Publication number
ATE231017T1
ATE231017T1 AT99956787T AT99956787T ATE231017T1 AT E231017 T1 ATE231017 T1 AT E231017T1 AT 99956787 T AT99956787 T AT 99956787T AT 99956787 T AT99956787 T AT 99956787T AT E231017 T1 ATE231017 T1 AT E231017T1
Authority
AT
Austria
Prior art keywords
test set
sampling system
quality testing
iontophoretic sampling
analytes
Prior art date
Application number
AT99956787T
Other languages
English (en)
Inventor
Qiang Chen
Brian S Kersten
David M Liu
Christina Wu
Original Assignee
Cygnus Therapeutic Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cygnus Therapeutic Systems filed Critical Cygnus Therapeutic Systems
Application granted granted Critical
Publication of ATE231017T1 publication Critical patent/ATE231017T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/104998—Glucose, ketone, nitrate standard or control

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Sampling And Sample Adjustment (AREA)
AT99956787T 1998-10-28 1999-10-27 Testsatz und verfahren zur qualitätsprüfung von einem iontophoretischen probenahmesystem ATE231017T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10602498P 1998-10-28 1998-10-28
PCT/US1999/025466 WO2000024455A1 (en) 1998-10-28 1999-10-27 Kit and method for quality control testing of an iontophoretic sampling system

Publications (1)

Publication Number Publication Date
ATE231017T1 true ATE231017T1 (de) 2003-02-15

Family

ID=22309069

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99956787T ATE231017T1 (de) 1998-10-28 1999-10-27 Testsatz und verfahren zur qualitätsprüfung von einem iontophoretischen probenahmesystem

Country Status (7)

Country Link
US (1) US6391643B1 (de)
EP (1) EP1117461B1 (de)
JP (1) JP2002528190A (de)
AT (1) ATE231017T1 (de)
CA (1) CA2350068A1 (de)
DE (1) DE69904956T2 (de)
WO (1) WO2000024455A1 (de)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6587705B1 (en) 1998-03-13 2003-07-01 Lynn Kim Biosensor, iontophoretic sampling system, and methods of use thereof
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6949816B2 (en) 2003-04-21 2005-09-27 Motorola, Inc. Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
EP1397068A2 (de) 2001-04-02 2004-03-17 Therasense, Inc. Gerät und verfahren zur blutzuckerverfolgung
WO2003000127A2 (en) * 2001-06-22 2003-01-03 Cygnus, Inc. Method for improving the performance of an analyte monitoring system
ATE507766T1 (de) 2002-03-22 2011-05-15 Animas Technologies Llc Leistungsverbesserung einer analytenüberwachungsvorrichtung
DE10397002B4 (de) 2002-07-02 2015-04-30 Panasonic Healthcare Holdings Co., Ltd. Biosensor, Biosensorchip und Biosensoreinrichtung
EP1556061B1 (de) * 2002-10-04 2007-04-18 Photokinetix Inc Photokinetische abgabe von biologisch aktiven subtanzen unter verwendung von pulsierendem inkohaerentem licht.
US7018345B2 (en) * 2002-12-06 2006-03-28 Hisamitsu Pharmaceutical Co., Inc. Iontophoresis system
US20060129035A1 (en) * 2002-12-27 2006-06-15 Kaoru Asano Devices, methods, and systems for measuring analytes extracted through skin
AU2003303597A1 (en) 2002-12-31 2004-07-29 Therasense, Inc. Continuous glucose monitoring system and methods of use
JP4381705B2 (ja) * 2003-03-26 2009-12-09 シスメックス株式会社 経皮的分析物抽出システムと分析システムおよび経皮的分析物抽出方法と分析方法
US7862519B1 (en) * 2003-05-21 2011-01-04 Isense Corporation Easy-to-use multi-use body fluid specimen collection and analyte sensing assembly
US8066639B2 (en) 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US20040267283A1 (en) * 2003-06-25 2004-12-30 Daniela Mavor Method, device and kit for body decoration
JP2007533346A (ja) * 2003-08-15 2007-11-22 アニマス・テクノロジーズ・リミテッド・ライアビリティ・カンパニー 生理学的分析対象のモニタリングに使用するマイクロプロセッサ、デバイス、および方法
JP2005137416A (ja) * 2003-11-04 2005-06-02 Sysmex Corp 経皮的分析物抽出システム及び経皮的分析物分析システム
CN1636505B (zh) * 2004-01-09 2011-11-09 希森美康株式会社 提取器具、提取装置和血糖值测量装置
EP1561418B1 (de) * 2004-02-03 2011-08-17 Sysmex Corporation Analysegerät, Patrone, Patronenkit
CA2556331A1 (en) 2004-02-17 2005-09-29 Therasense, Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US20050197554A1 (en) * 2004-02-26 2005-09-08 Michael Polcha Composite thin-film glucose sensor
US7590454B2 (en) * 2004-03-12 2009-09-15 Boston Scientific Neuromodulation Corporation Modular stimulation lead network
US20050203600A1 (en) * 2004-03-12 2005-09-15 Scimed Life Systems, Inc. Collapsible/expandable tubular electrode leads
US20060009727A1 (en) * 2004-04-08 2006-01-12 Chf Solutions Inc. Method and apparatus for an extracorporeal control of blood glucose
GB2414675B (en) * 2004-06-05 2006-09-06 Dewan Fazlul Hoque Chowdhury Transdermal drug delivery device
US7937160B2 (en) * 2004-12-10 2011-05-03 Boston Scientific Neuromodulation Corporation Methods for delivering cortical electrode leads into patient's head
US20080103374A1 (en) * 2005-01-19 2008-05-01 Sysmex Corporation Analyzer and Cartridge for Extracting Analyte
US20100168535A1 (en) * 2006-04-12 2010-07-01 Mark Ries Robinson Methods and apparatuses related to blood analyte measurement system
US20090156975A1 (en) * 2007-11-30 2009-06-18 Mark Ries Robinson Robust System and Methods for Blood Access
US20090088615A1 (en) * 2007-10-01 2009-04-02 Mark Ries Robinson Indwelling Fiber Optic Probe for Blood Glucose Measurements
US20090054754A1 (en) * 2007-08-21 2009-02-26 Mcmahon Dave Clinician-controlled semi-automated medication management
US20090048576A1 (en) * 2007-08-13 2009-02-19 Mark Ries Robinson Managing Cross-contamination in Blood Samples Withdrawn from a Multilumen Catheter
US8323194B2 (en) * 2009-12-18 2012-12-04 Inlight Solutions, Inc. Detection of bubbles during hemodynamic monitoring when performing automated measurement of blood constituents
US20100094114A1 (en) * 2008-10-09 2010-04-15 Mark Ries Robinson Use of multiple calibration solutions with an analyte sensor with use in an automated blood access system
WO2009117416A1 (en) * 2008-03-17 2009-09-24 Luminous Medical, Inc. Biological sample quality determination
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
EP1954190A4 (de) * 2005-11-15 2010-10-13 Luminous Medical Inc Blutanalytbestimmungen
ATE484233T1 (de) * 2005-12-16 2010-10-15 Bayer Healthcare Llc Sensorenanordnung zur transdermalen analyse und verfahren zu ihrer anwendung
WO2007093981A2 (en) * 2006-02-15 2007-08-23 Medingo Ltd. Systems and methods for sensing analyte and dispensing therapeutic fluid
US20170188898A1 (en) * 2006-03-28 2017-07-06 Arkal, Inc. Devices and methods for enhanced skin perforation for continuous glucose monitoring
US7620438B2 (en) 2006-03-31 2009-11-17 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US7920907B2 (en) 2006-06-07 2011-04-05 Abbott Diabetes Care Inc. Analyte monitoring system and method
EP2063762A1 (de) * 2006-09-06 2009-06-03 Medingo Ltd. Flüssigkeitsabgabesystem mit optischer messung der analytenkonzentrationsspiegel
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
EP2152148A2 (de) * 2007-05-07 2010-02-17 Medingo Ltd. Kolbenausgabe von flüssigkeiten in den körper mit analytkonzentrationsüberwachung
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8268638B2 (en) 2007-07-18 2012-09-18 Advantageous Systems, Llc Methods and apparatuses for detecting analytes in biological fluid of an animal
US8615281B2 (en) * 2007-11-21 2013-12-24 Medingo Ltd. Hypodermic optical monitoring of bodily analyte
US20100256593A1 (en) * 2007-11-21 2010-10-07 Ofer Yodfat Analyte Monitoring and Fluid Dispensing System
KR100950584B1 (ko) * 2008-04-07 2010-04-01 주식회사로케트전기 전지 일체형 이온토포레시스 패치
GB0811874D0 (en) * 2008-06-30 2008-07-30 Nemaura Pharma Ltd Patches for reverse iontophoresis
EP2355865A2 (de) 2008-09-02 2011-08-17 Medingo Ltd. Fernsteuerung für fluidspendevorrichtung mit einer wiederaufladbaren energiequelle
AU2009293019A1 (en) 2008-09-19 2010-03-25 Tandem Diabetes Care Inc. Solute concentration measurement device and related methods
WO2010045247A1 (en) * 2008-10-14 2010-04-22 Vivomedical, Inc. Sweat glucose sensors and collection devices for glucose measurement
CN102333487A (zh) * 2008-12-09 2012-01-25 佩妮拉·阿布哈姆森 用于微透析取样的方法及装置
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
GB2467377A (en) 2009-02-02 2010-08-04 Nemaura Pharma Ltd Transdermal patch with extensor means actuated to expel drug towards the skin of a patient
WO2010127050A1 (en) 2009-04-28 2010-11-04 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
WO2010138856A1 (en) 2009-05-29 2010-12-02 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
WO2011026147A1 (en) 2009-08-31 2011-03-03 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US8993331B2 (en) 2009-08-31 2015-03-31 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
EP2482720A4 (de) 2009-09-29 2014-04-23 Abbott Diabetes Care Inc Verfahren und vorrichtung zur bereitstellung einer benachrichtigungsfunktion in analytüberwachungssystemen
WO2011064780A2 (en) 2009-11-30 2011-06-03 Medingo Ltd. Analyte monitoring and fluid dispensing system
US9989522B2 (en) 2011-11-01 2018-06-05 Medtronic Minimed, Inc. Methods and materials for modulating start-up time and air removal in dry sensors
WO2013070794A2 (en) 2011-11-07 2013-05-16 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
WO2019069109A1 (es) * 2017-10-04 2019-04-11 Shimomoto Sanchez David Dispositivo biosensor y método para la medición de glucosa de manera no invasiva
EP4358842A4 (de) * 2021-06-22 2024-10-02 Ege Ueniversitesi Tragbare biomedizinische vorrichtungen zur diagnose, identifizierung, überwachung und vorhersage von grossen herzereignissen und akuten koronarsyndromfällen

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU597890B2 (en) 1986-03-14 1990-06-14 Drug Delivery Systems Inc. Transdermal drug applicator and electrodes therefor
US5362307A (en) 1989-01-24 1994-11-08 The Regents Of The University Of California Method for the iontophoretic non-invasive-determination of the in vivo concentration level of an inorganic or organic substance
JP2907342B2 (ja) 1988-01-29 1999-06-21 ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア イオン滲透非侵襲的サンプリングまたは送出装置
US5139023A (en) 1989-06-02 1992-08-18 Theratech Inc. Apparatus and method for noninvasive blood glucose monitoring
US5115805A (en) 1990-02-23 1992-05-26 Cygnus Therapeutic Systems Ultrasound-enhanced delivery of materials into and through the skin
JPH09503924A (ja) 1993-07-16 1997-04-22 シグナス，インコーポレイテッド 非侵襲性グルコースモニター
US5771890A (en) 1994-06-24 1998-06-30 Cygnus, Inc. Device and method for sampling of substances using alternating polarity
DE69519023T2 (de) 1994-06-24 2001-06-13 Cygnus, Inc. Einrichtung zur iontophoretischen probennahme
WO1997002811A1 (en) 1995-07-12 1997-01-30 Cygnus, Inc. Hydrogel patch
US5989409A (en) 1995-09-11 1999-11-23 Cygnus, Inc. Method for glucose sensing
US5735273A (en) 1995-09-12 1998-04-07 Cygnus, Inc. Chemical signal-impermeable mask
EP0812150A4 (de) 1995-12-28 1999-03-10 Cygnus Therapeutic Systems Kontinuierliche überwachung für physiologische probenbestandteile
US5954685A (en) 1996-05-24 1999-09-21 Cygnus, Inc. Electrochemical sensor with dual purpose electrode
US6139718A (en) 1997-03-25 2000-10-31 Cygnus, Inc. Electrode with improved signal to noise ratio
DK1037686T3 (da) * 1997-12-11 2006-01-02 Alza Corp Apparat til forögelse af transdermal gennemströmning af midler
US6587705B1 (en) 1998-03-13 2003-07-01 Lynn Kim Biosensor, iontophoretic sampling system, and methods of use thereof
JP3600158B2 (ja) * 1998-05-13 2004-12-08 シグナス， インコーポレイテッド 生理学的分析物のモニタリング
CA2330629C (en) 1998-05-13 2007-04-03 Cygnus, Inc. Method and device for predicting physiological values
DK1053043T3 (da) 1998-05-13 2002-11-18 Cygnus Therapeutic Systems Opsamlingsenheder til transdermale prøveudtagningssystemer
ES2213369T3 (es) * 1998-05-13 2004-08-16 Cygnus, Inc. Procesamiento de señal para medicion de analitos fisiologicos.
US6180416B1 (en) * 1998-09-30 2001-01-30 Cygnus, Inc. Method and device for predicting physiological values
USD438807S1 (en) 1998-10-28 2001-03-13 Cygnus, Inc. Cover for quality control testing of an iontophoretic sampling system

Also Published As

Publication number Publication date
EP1117461A1 (de) 2001-07-25
JP2002528190A (ja) 2002-09-03
CA2350068A1 (en) 2000-05-04
DE69904956D1 (de) 2003-02-20
DE69904956T2 (de) 2003-11-13
EP1117461B1 (de) 2003-01-15
US6391643B1 (en) 2002-05-21
WO2000024455A1 (en) 2000-05-04

Similar Documents

Publication Publication Date Title
DE69904956D1 (de) Testsatz und verfahren zur qualitätsprüfung von einem iontophoretischen probenahmesystem
DE69901743D1 (de) Biosensor, iontophoretischen Probenahmesystem, und Verfahren zur seiner Anwendung
DE68928266D1 (de) Verfahren und vorrichtung zur amperometrischen diagnostischen analyse
ATE266868T1 (de) Methode und vorrichtung zum elektrochemischen immunoassay mehrerer analyten
ATE129868T1 (de) Vorrichtung und verfahren zum nachweis von chemischen spezies.
DE60315373D1 (de) Vorrichtung und Verfahren zur Bestimmung der Konzentration von Analyten
DE60317422D1 (de) Mediator-stabilisierende Verbindung und Methoden zur Verwendung zur Detektion elektrochemischer Analyte
DE69718092D1 (de) Kontrolllösung und Verfahren um die Leistung einer elektrochemischen Vorrichtung zur Bestimmung der Konzentration eines Analyten im Blut zu testen
ATE137583T1 (de) Verfahren und vorrichtung zur bestimmung von chemischen spezies in körperflüssigkeit
DE69714630D1 (de) Biosensor und Verfahren zur quantitaven Analyse von biochemischen Substraten
DE60034479D1 (de) Vorrichtung und verfahren zum bestimmen der koagulation in flüssigproben
ATE68885T1 (de) Verfahren und mittel zur bestimmung von zellen in einer probe.
DE59609347D1 (de) Verfahren zur quantifizierung von tumorzellen in einer körperflüssigkeit und dazu geeignete testkits
DE69719057D1 (de) Verfahren zur signalverstärkung
ATE416384T1 (de) Verfahren und kit zum quantitativen und/oder qualitativen nachweis von komponenten in einer probe
DE69736336D1 (de) Verfahren zur messung von blutersatzstoffen
DE60031204D1 (de) VERFAHREN und KIT ZUM NACHWEIS UND ZUR IDENTIFIZIERUNG VON KRISTALLEN IN BIOLOGISCHEN FLÜSSIGKEITEN
ATE197507T1 (de) Verfahren und verbindungen zur detektion von analyten mittels remanenzmessung und deren verwendung
ATE135746T1 (de) Enzymatisches verfahren zur bestimmung der analyt-konzentration
DE60121547D1 (de) Electrochemisches verfahren zum nachweis von nukleinsäuren
DE69708102D1 (de) Verfahren und reagenz zur überwachung des blutspiegels von antiplättchen-verbindungen
ATE305980T1 (de) Verwendung von abfangsonden beim nachweis von nukleinsäuren
ATE184109T1 (de) Indikatorreagenzien zum nachweis oder zur messung von analyten, testsatz, der diese enthält, und verfahren zum nachweis oder zur messung
DE60026285D1 (de) Verfahren zur abschätzung des individuellen risikos einer irreversiblen nervenschädigung, das schritte zur quantitativen bestimmung der pepsinogen-i (pgi) und vitamin b12 konzentrationen umfasst
DE68915323D1 (de) Verfahren zum Nachweis einer spezifisch bindenden Substanz in Blut sowie Reagenzsatz zur Ausführung dieser Methode.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties